Both in Pharmaceuticals
Foghorn Therapeutics vs Pyxis Oncology
Over the past year FHTX returned −49.4% and PYXS returned −57.0%; their daily moves had a correlation of 0.17.
FHTX −49.4% PYXS −57.0%Growth of $1, one year, split-adjusted
| Metric | FHTX | PYXS |
|---|---|---|
| Price | $2.13 | $1.64 |
| Market cap | $126.5M | $136.8M |
| Today | 0.00% | −2.96% |
| 1 month | +6.5% | −26.8% |
| 6 months | −54.1% | −10.4% |
| Year to date | −60.6% | +42.6% |
| 1 year | −51.7% | −53.9% |
| Revenue growth (YoY) | +112.7% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | 12.4× |
| Net cash | $167.6M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 99.1% | 112.4% |
| Short % of float | 7.3% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).